SRAGE and early signs of cardiac target organ damage in mild hypertensives.

ABSTRACT:

Background

Soluble Receptor for Advanced Glycation End Products (sRAGE) may be considered a marker inversely related to inflammation and its participation has been established in patients with advanced atherosclerotic vascular diseases. However, it is still unknown whether sRAGE reduction could be early metabolic change in the first stage of hypertension and initial hypertension-associated cardiac damage. We sought to determine the sRAGE values in otherwise healthy, untreated and recently diagnosed mild hypertensives and evaluate their association with blood pressure (BP) values, metabolic parameters, and with subclinical initial signs of cardiac target organ damage (TOD).

Methods

sRAGE were measured in 100 hypertensive and 100 normotensive subjects matched for age, gender and body mass index (BMI), submitted to a clinic visit and both ambulatory BP monitoring and echocardiography to determine the presence of initial cardiac TOD (presence of signs of left ventricular hypertrophy: left ventricular mass indexed for height^2.7 (LVMi)?>?48 g/m^2.7 for men and?>?44 g/m^2.7 for women and/or increased left atrial volume 4-chamber indexed for body surface area (LAVi)?>?34 ml/m²).

Results

sRAGE levels were similar between hypertensive and normotensive subjects and were not significantly correlated with office and 24-h BPs values. However, when subgrouping the hypertensive patients in Hyp-TOD and Hyp-withoutTOD, sRAGE was found to be different among the three groups (p?=?0.030), being lower in the Hyp-TOD group than the values of both Hyp-withoutTOD (p?=?0.038) and normotensives (p?=?0.038). In hypertensive patients sRAGE was negatively related with both LVMi (r?=?-?0.239, p?=?0.034) and LAVi (r?=?-?0.315, p?=?0.005) and was independently related to cardiac TOD also in multivariable analysis.

Conclusions

In this population of mild hypertensives, low circulating sRAGE may be a very early marker of initial TOD, suggesting the possible participation of oxidative stress in initial cardiac changes in human hypertension.

SUBMITTER: Maresca AM 

PROVIDER: S-EPMC6371567 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature